The IBM Healthcare and Life Sciences Clinical Genomics Solution enables research institutions and biopharmaceutical companies across the world to integrate, store, analyze and better understand genotypic and phenotypic data for medical research and patient care. Critical components of the solution include business consultant services, business strategy and process re-engineering, and:
The Medical Information: interfaces with hospital and research systems to capture and de-identify information from each patient or research encounter, helping to ensure patient security and privacy
The Medical Information Broker: pulls data from multiple healthcare institutions and diagnostic laboratories to be stored in the Medical Information Repository
The Medical Information Repository: centralizes data for integrated clinical and high-throughput research, enabling an organization to fully leverage its information assets
IBM DB2 ® Information Integrator: Helps increase researchers’ productivity by providing seamless access to additional data in external databases such as Medline, dbSNP and GenBank
IBM Business Partner Platforms: complete solution through powerful technologies offered by IBM Business Partners
"Globally, healthcare is undergoing a profound transformation toward targeted therapeutics and treatment regimens. Working with our Business Partners, IBM is deeply committed to shedding light on the critical role information technology will play in personalized medicine," said Mike Svinte, vice president, information-based medicine, IBM. "We’ve built our clinical genomics services practice to aid this transformation by enhancing drug discovery and medical practices with knowledge generated from diverse clinical and biomedical data. Our new solution will help clients achieve this vision of information-based medicine by accelerating our understanding of disease."
The IBM Healthcare and Life Sciences Clinical Genomics Solution reflects IBM’s deep commitment to advancing healthcare and life sciences and leverages cutting-edge work by IBM Research as well as companies such as the Mayo Clinic and the H. Lee Moffitt Cancer Center and Research Institute.
Information-based medicine is the use of IT to cross-reference clinical information -- such as patient records, family histories and lab tests -- with knowledge about the human genome. By understanding illnesses on the molecular level, including gene variations linked to disease or drug response, doctors may be able to make more precise diagnoses and tailor treatment decisions. Similarly, drug makers can work to develop more targeted treatment therapies and identify potential clinical trail participants more effectively.
The IBM Healthcare and Life Sciences Clinical Genomics Solution can help facilitate companies’ compliance with rigorous patient privacy and security standards, such as HIPAA. Every implementation leverages IBM’s security framework, which is based on the Tivoli® suite of products. Tivoli applications help institutions define consistent security policies -- based on both internal requirements and industry standards -- and monitor compliance. Other products used in the clinical genomics solution include the IBM ® pSeries®, IBM DB2 Universal Database® and IBM WebSphere® Portal Server.
Source:
IBM
Related stories:
Bacteria beware: MIT graduate invents knock-out punch for antibiotic resistance
MIT graduate student and synthetic biologist Timothy Lu is passionate about tackling problems that pose threats to human health. His current mission: to destroy antibiotic-resistant bacteria.
IBM Triples Performance of World's Fastest Supercomputer
IBM’s newest supercomputer, Blue Gene/P, is nearly three times as fast as its predecessor and is designed to fit in smaller spaces and use less electricity than other commercially available models.
Taiwanese Researchers Introduce Blink of the Eye Transmission Speed System On A Chip
(PhysOrg.com) -- A world-wide expert on wireless communications, Professor Jri Lee of the National Taiwan University (NTU) and UCLA PhD conferred has created a system on a chip (SOC) with transmission speeds 100 times faster than WiFi and 350 times faster than 3.5G cell phones. Professor Jri Lee's team broke the speed record with the SoC design which is about 1/10th the size and cost of existing chips. Preliminary figures indicate the SoC chip can be massed-produced for less than $1 per unit.
Yahoo's Hadoop transforming how data is analyzed
Behind Yahoo's push to open up Web search and advertising is software powerful enough to sort through the entire Library of Congress in less than half a minute.
'Security-on-a-Stick' to protect consumers and banks from the most sophisticated hacker attacks
(PhysOrg.com) -- Resembling a memory stick with an integrated display, a prototype USB device developed at IBM's Zurich Research Lab brings a new level of security to online banking for consumers. Pilot devices are ready and available to banks for trials.
IBM Delivers Breakthrough Storage Capability on Blade Computing Solution Designed for the Office
IBM announced today a storage breakthrough in blade computing that will allow small and medium-sized customers and branch offices to consolidate multiple storage devices onto a single blade computing system. Building on the leadership design of IBM's office-ready blade solution, customers can now share information across all blade servers in a single system to help improve utilization and reliability while reducing costs.
New research can help product manufacturers effectively shift to service-centric business strategies
According to research conducted at the University of Washington, manufacturing firms can increase shareholder value by transitioning to services, but there are some important caveats.
IBM Develops Computational Scaling Solution for Next Generation '22nm' Semiconductors
In response to ever increasing demands for smaller, more powerful and energy-efficient devices for cloud computing and high-performance servers, IBM today announced the semiconductor industry's first computationally based process for production of next generation 22nm semiconductors. Known as Computational Scaling (CS) -- a process that enables the production of complex, powerful and energy-efficient semiconductors at 22nms and beyond -- this new initiative will feature support from several of IBM's key partners initially including Mentor Graphics and Toppan Printing.